RSS

Durbin

A new Managed Access Program (MAP) for the treatment of sickle cell disease has been announced for Emmaus Life Sciences’ pharmaceutical grade L-glutamine treatment (PGLG). more

News

Leslie Morgan, CEO of Durbin talks about industry regulations, Managed Access Programmes and the future of pharma more

Opinion

Robert Donnell, Durbin, specialist distributor of pharmaceuticals, medical and relief supplies, examines the increasing prevalence of managed access programmes and the challenges faced in getting the most appropriate drug to the patient in time more

Opinion

Barts Health Pharmaceuticals has appointed Durbin to distribute its UK Specials products more

News